Allied Market Research

2024

Diabetic Macular Edema Treatment Market

Diabetic Macular Edema Treatment Market Size, Share, Competitive Landscape and Trend Analysis Report, by Drug, by Therapy, by Dosage form and, by Distribution network : Global Opportunity Analysis and Industry Forecast, 2023-2032

LS : Healthcare

  • Jun 2024

  • Pages: NA

  • Tables: NA

  • Charts: NA

Select an option
Cloud Access (10% Off) $3,690 $3,321
Business User License (10% Off) $5,820 $5,238
Enterprise License (10% Off) $9,870 $8,883
Library Membership (15% Off) $1,175 $999
Enquiry Now
Author's: | Roshan Deshmukh
Publish Date:
Enquire Before Buying Customization Request Speak with Analyst

Get Sample to Email

  Diabetic Macular Edema Treatment Market Report Highlights

Aspects Details
icon_5
By Drug
  • ANTI VEGF DRUGS
  • CORTICOSTEROID DRUGS
  • OTHER DRUGS
icon_6
By Therapy
  • LASER PHOTOCOAGULATION THERAPY
  • PHARMACOLOGICAL THERAPY
icon_7
By Dosage form
  • INTRAVITREAL INJECTION
  • INTRAVITREAL IMPLANTS
icon_8
By Distribution network
  • HOSPITAL PHARMACIES
  • RETAIL PHARMACIES
icon_9
By Region
  • North America  (U.S., Canada, Mexico)
  • Europe  (France, Germany, Italy, Spain, UK, Rest of Europe)
  • Asia-Pacific  (China, Japan, India, South Korea, Australia, Rest of Asia-Pacific)
  • LAMEA  (Brazil, South Africa, Saudi Arabia, Rest of LAMEA)
icon_10
Key Market Players

Kubota Pharmaceutical Holdings Co. Ltd., Novartis AG, Pfizer Inc., Bayer AG, F. Hoffmann-La Roche Ltd, Alimera Sciences, ALLERGAN, Oculis, GlaxoSmithKline plc, Regeneron Pharmaceuticals Inc.

Loading Table Of Content...

Individual sections of the reports are available for purchase.
Would you like to see a breakdown of prices by section?

Diabetic Macular Edema Treatment Market

Global Opportunity Analysis and Industry Forecast, 2023-2032

help@alliedmarketresearch.com